Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.67%715.66B | -1.55%3.42T | -2.30%690.3B | 4.96%3.48T | 3.85%1.08T | 3.76%844.48B | 5.85%842.26B | 7.11%706.54B | 9.92%3.31T | 13.73%1.04T |
| Cost of revenue | -0.13%499.47B | -4.39%2.36T | -3.67%500.13B | 4.95%2.47T | 5.92%748.98B | 3.89%597.5B | 4.25%605.74B | 5.64%519.19B | 10.67%2.35T | 13.08%707.15B |
| Gross profit | 13.68%216.19B | 5.44%1.06T | 1.50%190.17B | 4.97%1.01T | -0.48%335.01B | 3.43%246.98B | 10.17%236.52B | 11.40%187.36B | 8.10%958.25B | 15.13%336.61B |
| Operating expense | -2.60%180.8B | -1.69%804.06B | -5.04%185.63B | 3.81%817.85B | -2.89%216.81B | 4.91%205.16B | 8.05%200.4B | 6.52%195.48B | 4.50%787.8B | 7.80%223.26B |
| Selling and administrative expenses | -0.22%183.68B | -4.49%777.42B | -5.80%184.09B | 2.56%814.01B | 0.49%216.51B | 3.26%201.58B | 4.04%200.51B | 2.69%195.41B | 4.03%793.7B | 2.68%215.46B |
| -General and administrative expense | -0.22%183.68B | -4.49%777.42B | -5.80%184.09B | 2.56%814.01B | 0.49%216.51B | 3.26%201.58B | 4.04%200.51B | 2.69%195.41B | 4.03%793.7B | 2.68%215.46B |
| Other operating expenses | -286.66%-2.88B | 594.89%26.64B | 2,170.59%1.54B | 164.98%3.83B | -96.19%297M | 947.66%3.58B | 98.42%-115M | 101.00%68M | 35.05%-5.9B | 384.49%7.8B |
| Operating profit | 679.49%35.39B | 36.43%256.5B | 155.88%4.54B | 10.31%188.01B | 4.28%118.2B | -3.27%41.82B | 23.66%36.12B | 47.04%-8.13B | 28.61%170.45B | 32.94%113.35B |
| Net non-operating interest income (expenses) | -327.22%-4.36B | 19.90%-6.62B | -52.78%1.92B | -22.94%-8.27B | 28.59%-2.43B | 29.34%-7.46B | -22,300.00%-2.44B | -43.76%4.06B | -203.03%-6.73B | -139.24%-3.4B |
| Non-operating interest income | -40.88%3.3B | 1.55%9.96B | -19.97%5.59B | -10.05%9.8B | 0.58%2.97B | -21.18%1.97B | -18.85%1.69B | -24.66%6.98B | -39.09%10.9B | -73.77%2.95B |
| Non-operating interest expense | 108.89%7.66B | -8.26%16.58B | 25.71%3.67B | 2.54%18.07B | -15.03%5.4B | -27.78%9.43B | 99.32%4.13B | 42.92%2.92B | 55.05%17.62B | 145.10%6.35B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 110.96%1.07B | -291.82%-10.1B | -711.31%-9.78B | 33.38%5.27B | 806.67%1.09B | 122.13%1.82B | -50.49%762M | 8.70%1.6B | -26.65%3.95B | -91.57%120M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 1,066.08%32.1B | 29.60%239.77B | -34.92%-3.32B | 10.34%185.01B | 6.17%116.86B | 8.02%36.18B | 11.97%34.44B | 62.95%-2.46B | 16.09%167.67B | 15.43%110.07B |
| Income tax | 365.65%12.65B | 172.01%55.11B | -37.81%2.72B | -43.97%20.26B | -132.52%-5.15B | 35.79%11.23B | 16.33%9.82B | 21.31%4.37B | 394.73%36.16B | 156.83%15.85B |
| Net income | 422.17%19.46B | 12.09%184.66B | 11.58%-6.04B | 25.27%164.75B | 29.49%122.01B | -1.09%24.95B | 10.32%24.62B | 33.35%-6.83B | -16.07%131.52B | -23.54%94.22B |
| Net income continuous operations | 422.17%19.46B | 12.09%184.66B | 11.58%-6.04B | 25.27%164.75B | 29.49%122.01B | -1.09%24.95B | 10.32%24.62B | 33.35%-6.83B | -16.07%131.52B | -23.54%94.22B |
| Noncontrolling interests | 171.92%146M | -37.75%9.48B | -136.38%-203M | -10.49%15.23B | 7.21%6.53B | 35.21%3.83B | -3.64%4.32B | -84.56%558M | 10.31%17.02B | -11.61%6.09B |
| Net income attributable to the company | 430.88%19.31B | 17.16%175.18B | 21.01%-5.84B | 30.59%149.52B | 31.03%115.48B | -5.67%21.13B | 13.83%20.3B | 46.70%-7.39B | -18.95%114.5B | -24.25%88.13B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 430.88%19.31B | 17.16%175.18B | 21.01%-5.84B | 30.59%149.52B | 31.03%115.48B | -5.67%21.13B | 13.83%20.3B | 46.70%-7.39B | -18.95%114.5B | -24.25%88.13B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 430.82%14.49 | 17.15%131.5 | 21.05%-4.38 | 32.21%112.25 | 32.52%86.694 | -5.09%15.858 | 16.22%15.244 | 45.48%-5.548 | -18.13%84.902 | -23.40%65.418 |
| Diluted earnings per share | 430.82%14.49 | 17.14%131.49 | 21.05%-4.38 | 32.21%112.25 | 32.52%86.694 | -5.10%15.856 | 16.21%15.242 | 45.49%-5.548 | -18.14%84.9 | -23.40%65.418 |
| Dividend per share | 0 | 16.67%28 | 0 | 9.09%24 | 9.09%12 | 0 | 9.09%12 | 0 | 10.00%22 | 10.00%11 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |